Total flavonoids of Chrysanthemum indicum L inhibit acute pancreatitis through suppressing apoptosis and inflammation

Acute pancreatitis (AP) is one of the most common acute abdomen. Inflammation and apoptosis are closely linked with AP development. Total flavonoids of Chrysanthemum indicum L (TFC) has been proved to inhibit inflammation and apoptosis. If TFC could suppress AP remains unclear. AP animal and cell models were established with Cerulein. The pancreatic tissue injury was measured with HE staining. Inflammatory factors were detected with ELISA method. The protein expression was evaluated with Western blotting. Inhibition of AP in vivo was achieved by TFC by inhibiting serum amylase, myeloperoxidase (MPO), and water content of pancreatic tissue. The increased inflammatory response and activation of NF-kappa B signaling pathway in AP rats were inhibited after TFC treatment. The activation of NF-kappa B signaling pathway, increase of cell apoptosis and inflammatory factors in AR42J cells were suppressed by TFC. We demonstrated that TFC could significantly inhibit AP through restraining serum amylase, MPO, water content of pancreatic tissue, inflammation levels, apoptosis, and NF-kappa B signaling pathway activation. This study might clarify the potential inhibition mechanism of TFC in AP development.

Automated summary

Total flavonoids of Chrysanthemum indicum L (TFC) can suppress the development of acute pancreatitis by inhibiting inflammation and apoptosis. The study demonstrated that TFC can inhibit acute pancreatitis by restraining serum amylase, myeloperoxidase, water content of pancreatic tissue, inflammation levels, apoptosis, and NF-kappa B signaling pathway activation. This research provides insight into the potential inhibition mechanism of TFC in acute pancreatitis development.